Originally broadcast November 22, 2022
When we have a guest like “Shark Tank” star Mark Cuban, it’s can be hard to keep up with all his thoughts. He was a bundle of energy in November 2022 explaining his then-new venture trying to reform how Americans can purchase lower-priced drugs; he called it “dunking on the pharma industry.” Since our conversation, experts say Cuban has become a major disrupter in generic drug pricing. Cost Plus now offers 2,500 drugs and has signed up a large list of health systems.
Join us for this encore presentation as hosts Mark Masselli and Margaret Flinter ask Cuban to explain how his approach also includes introducing transparency to drug pricing.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
The new Rural Health Transformation Program aims to improve “healthcare access, quality, and outcomes” with…
New research. New technology. New possibilities. On this special 2025 Rewind and Look Ahead episode…
Health care policy faced major upheavals during the past 12 months and the effects are…
Eighty percent of maternal deaths in the United States are considered preventable. So why do…
Originally broadcast December 11, 2025 Congress is scrambling to find a solution to the enhanced…
Originally broadcast December 4, 2025 The doctor who once led the Centers for Disease Control…